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1CHAPTER I
INTRODUCTION
2INTRODUCTION
The potential therapeutic and health-promoting effects of dietary components
are attracting considerable interest, because along with changes in dietary habits and
lifestyle, various lifestyle-related diseases, such as hyperlipidemia, obesity and diabetes,
are increasing.  Onion (Allium cepa L.) and garlic (Allium sativum L.) have been long
used as traditional medicines and are thought to have various effects, including prevention
of heart diseases (Augusti, 1996).  Among the potential therapeutic application of garlic,
the hypolipidemic effects have been reported in studies in human hepatocytes (Gebhardt,
1993), as well as in experimental rats (Kamanna and Chandrasekhara, 1982; Ogawa et
al., 1993; Chi et al., 1982) and chickens (Asaf et al., 1983).  Adler et al.(1997) reported
that garlic supplementation significantly decreased both total cholesterol and low density
lipoprotein (LDL)-cholesterol in hypercholesterolemia in humans. It has been also
reported that oils of onion and garlic extracts inhibit platelet aggregation in vitro
(Morimitsu et al., 1990).  Furthermore, the mixtures of onion and garlic exhibited a
synergistic effect of inhibition on platelet aggregation compared to each individual one
(Morimitsu et al, 1992).
On the other hand, epidemiological studies suggest that onion feeding has
beneficial effects on the prevention for some diseases (Augusti et al., 1975; Causey et al.,
2000).  Some in vitro studies indicated that onions have been reported to exhibit anti-
bacterial (Al-Delaimy and Ali, 1970) and anti-platelet aggregative (Harata and Matsushita,
1996).  Recently, Chen et al. (1999) investigated whether onion extracts could alter
3vascular responses in vitro in the thoracic aorta of SD-rats because onion has been
consumed for the prevention of cardiovascular disorders in Asian countries. They
demonstrated that Welsh onion extracts caused vasodilation on precontracted vessel rings
and concluded that boiled onion extract could stimulate the release of an endothelium-
derived contracting factor, which was assumed to be thromboxane A2.  Helen et al.
(2000) reported that onion oil was an effective antioxidant against the oxidative damage
caused by nicotine.  Sheela et al. (1995) studied the anti-diabetic effects of onion and
garlic sulfoxide amino acids in rats, and they found that on oral administration of onion
and garlic sulfoxide amino acids to alloxan-diabetic rats was ameliorated as comparable
to rats treated with insulin.  However, it is still scarce of the information on the effect
of onion on physiological functions.  In addition, little is known about components of
onion responsible for the biological activities.  To answer these questions, we conducted
to study on the effects of onion on lipid synthesis and lipoprotein assembly.  It is known
that lipid and lipoprotein metabolism were altered under the many physiological
conditions and by several mechanisms. Typical metabolic disorder is a hyperlipidemia,
which is related to the cause of many lifestyle-related diseases.
Hyperlipidemia is a syndrome characterized by excessive accumulation of lipids
in the bloodstream (Loscalzo and Sniderman, 1993).  Apolipoprotein B100 (apoB100)-
containing lipoproteins are assembled in the liver.  ApoB100-containing lipoproteins are
synthesized with supply of TAG, phospholipid, cholesterol, and apoB100.  Recently, it
is also confirmed that microsomal TAG transfer protein (MTP) is necessary to assemble
these lipoproteins (Wetterau et al., 1992).  ApoB100 is an essential protein component
4of very low density lipoprotein (VLDL) and LDL, and is required for the intracellular
assembly and secretion of these lipoproteins (Fig.1) (Scott et al., 1994).  However, the
overproduction of VLDL in the liver resulted in a hyperlipidemia.  Triacylglycerol (TAG)
biosynthesis is catalyzed by three enzymes, glycerol-3-phosphate acyltransferase,
phosphatidate phosphohydrolase, and diacylglycerol acyltransferase (DGAT) in the liver
(Haggsman et al., 1981; Owen et al., 1997) (Fig.2).  Phosphatidate phosphohydrolase
and DGAT are postulated to be key enzymes for TAG biosynthesis.  They are located
in endoplasmic reticulum as active forms (Brindley et al., 1984; Yanagita et al., 1987).
ApoB100, a 556 kDa hydrophobic protein, is synthesized in the endoplasmic
reticulum (ER) and shows LDL-receptor binding activity (Davis, 1999; Twisk et al.,
2000).  After synthesis, it is stabilized through binding with lipids, and then is secreted
as apoB100-containing lipoproteins into the bloodstream.  If sufficient lipid is not
available, hydrophobic apoB100 is unstable and undergoes degradation via the ubiquitin-
proteasome pathway (Fig. 3)(Fisher et al., 1997).  Therefore, the control of apoB100
expression in the cells is considered to be post-transcriptional (Gordon et al., 1996;
Yanagita et al., 1999-b).  It is known that VLDL plays an important role to transport TAG
as well as cholesterol to the tissues.
MTP catalyzes the transfer of TAG, cholesterol ester, and phosphatidylcholine
between membranes, which is formed in the lumen of microsomes isolated from the liver
and intestinal mucosa (Jamil et al., 1995; Benoist and Grand-Perret, 1997).  MTP is a
heterodimer consisting of two subunits of molecular mass of 58 kDa and 97 kDa. The 58
kDa component of MTP has been identified as the multifunctional protein, protein
5disulfide isomerase (Wetterau et al., 1990).  The large 97 kDa possesses the lipid transfer
activity.  The large subunit of MTP was not detectable in subjects with the disease
abetalipoproteinemia, a rare human genetic disease characterized by a defect in VLDL and
chylomicron assembly (Gregg and Wetterau, 1994; Wetterau et al., 1992).  It is known
that there are distinct relationships between the onset of coronary heart disease (CHD) and
higher levels of serum lipids and apoB100 (Cullen et al., 1997; Davis and Vance, 1996).
In the preliminary study, it was observed that dietary onion powder reduced
serum TAG levels in rats, suggesting the hypolipidemic activity of onion.  Allium species
such as onion and garlic contain relatively abundant amounts of sulfur-containing
compounds and they exert for the characteristic odor and taste (Brock, 1995; Matsukura,
1994).  Biological actions of onion and garlic are, in part, ascribed to sulfur-containing
compounds.  Thus, to extend the therapeutic application and to identify the components
responsible for the nutraceutical actions, we focused our study to investigate the effects
of main sulfur-containing compounds, cycloalliin, which is the derivatives of cysteine and
methionine, and sulfoxide compounds found in onion on the lipid and lipoprotein
metabolism.  In Chapter II, the effects of onion extract on the growth performance and
lipid metabolism were studied.  Cycloalliin, 3-(S)-methyl-1,4-thiazane-5-(R)-carboxylic
acid-(S)-oxide, is the most abundant sulfur-containing imino acid in onion and garlic.  It
has the great merit of being almost flavorless and stable (Table. 1-1)(Ueda et al., 1994).
In Chapter III, we studied the effects of cycloalliin on lipid metabolism and apoB100
secretion by using experimental rats and human hepatoma cell line, HepG2.
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     Table 1-1. Composition of major sulfur-containing compounds in onion
                                            (mg/100 g onion bulb)
                                             Raw        Heated
       Cycloalliin                             28.2         104.3
S-Methyl-cysteine sulfoxide　　　　　　　 46.5          41.5
S-Propenyl-L-cysteine sulfoxide　　　　　  82.3           8.9
γ-Glutamyl-S-propenyl-L-cysteine sulfoxide  69.3           2.4
S-(2-Carboxypropyl) glutathione           12.5            -
Glutathione                             0.4      　　 3.0
Cysteine                               13.7           6.5
Methionine 　11.5 　0.6
       Other compounds 　　　　 trace　        trace
                                              (Ueda et al., 1994)
In Chapter IV, we evaluated the effects of S-methyl cysteine, S-ethyl cysteine,
S-propyl cysteine, propyl-cysteine sulfoxide, DL-methionine sulfoxide, S-carboxymethyl
cysteine, and S-carboxyethyl cysteine from onion on lipid and apoB100-containing
lipoprotein metabolism in HepG2 cells.
7                  (Scott et al., 1994, Wetterau et al., 1992)
                  Fig.1. Lipid and lipoprotein metabolism
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                  (Haggsman et al., 1981; Owen et al., 1997)
Fig.2. Biosynthesis of triacylglycerol in the liver
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9                    (Fisher et al., 1997; Gordon et al., 1996)
Fig.3. Assembly and secretion of apoB100-containing lipoproteins in the liver
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CHAPTER II
Effects of onion extract on body weight, tissue weight,
and lipid metabolism in rats
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Part 1. Effects of onion extract on body weight, tissue weight, and lipid
metabolism in rats
1.  INTRODUCTION
Allium species such as onion and garlic has been used as medicine for centuries,
but there was little scientific support of its therapeutic properties until recently.  The lipid
lowering effect of garlic has been reported in several earlier trials (Augusti, 1996; Block,
1992).  Furthermore, garlic has been reported to have other medicinal properties including
a propensity to inhibit platelet aggregation and reduce cancer risk (Morimitsu et al., 1992;
Babu and Srinivasan, 1997).
However, little is known whether onion and associated sulfur-components have
medicinal properties similar to garlic.  The present study was undertaken to know whether
supplementation of onion extract to the diet affect body weight gain, tissue weights, and
lipid metabolism in experimental rats.
2.  MATERIALS AND METHODS
2.1 Experimental material and reagents
Commercial kits for measuring the concentrations of total cholesterol, glucose,
TAG, phospholipid and free fatty acid in serum were purchased from Wako Pure Chemical
Ind. (Osaka, Japan).  All other chemicals and reagents were of special grade available.
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2.2 Preparation of onion extract powder
Onion extract used was prepared as the procedure reported by Anno (2000).  In
brief, onions were blanched in water bath at 80 °C for 1 h, and then homogenated by using
a Warning blender.  After centrifugation at 8,000 rpm for 30 min, the resulting supernatant
was treated with cellulase (Cellulase A, Amono Seiyaku Co., Ltd., Osaka, Japan) and
glutaminase (Daiwa C-100, Daiwa Kagaku Co., Ltd., Osaka, Japan).  The samples were
heated at 90 °C for 60 min, spray-dried, and used as onion extract.  The cycloalliin content
of the onion extract was 0.55 g per 100 g, which is approximately 5-fold higher
concentration than that of the corresponding raw onion.
2.3 Experimental animals
Four-week-aged male SD-strain rats (125-135 g) were obtained from Kyudo
(Tosu, Japan) and maintained in an individual stainless-meshed cage on a temperature-
controlled room (24 °C) with a 12 h light/dark cycle.  They were divided into three groups
with equal body weight (6 rats in each group) after rearing with a stock pellet chow (CE-2,
CLEA, Tokyo, Japan) for 7 days.  Control group was given the semipurified atherogenic
diet containing 0.5 % cholesterol and 0.125 % sodium cholate.  The remaining two groups
were fed the same diets supplemented with 0.4 % and 1.2 % of onion extract.  The
composition of experimental diets is presented in Table 2-1.  The animals had free access
to the diet and water.  Food intake was recorded everyday, and body weight was recorded
every other day during the experimental period.  After 2 weeks, they were fasted for 5 h,
and then blood was collected from vena cava and the liver was excised under diethyl ether-
anesthesia.  The study was approved by Saga University Institutional Animal Care and
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Use Committee.
2.4 Lipid analyses
Lipids were extracted and purified by the method of Folch et al. (1957).  The
concentrations of hepatic TAG and cholesterol were measured by the methods of Fletcher
(1968) and Sperry and Webb (1950), respectively.  The hepatic phospholipid was
quantified by phosphorus content as reported previously, and multiplied by 25 to
extrapolate the phospholipid molecules (Barlett, 1959).  Serum was separated by
centrifuging the blood at 3,000 rpm for 15 min.  The concentrations of total cholesterol,
HDL-cholesterol, TAG, and phospholipid in the serum were measured enzymatically with
commercial kits supplied by Wako Pure Chemical Ind. (Osaka, Japan).
2.5 Preparation of liver subcellular fractions
Liver homogenates and subcellular fractions were prepared as described by
Yanagita et al.(1987).  In brief, a piece of liver was homogenized in 4 volume of ice-cold
0.25 M sucrose homogenate solution containing 1 mM EDTA, 0.2 mM dithiothreitol, and
10 mM Tris-HCl (pH 7.4).  The homogenate was centrifuged at 1,000×g for 10 min to
sediment nuclei and cell debris, and the supernatant was then centrifuged at 20,000×g for
20 min at 4 °C to sediment mitochondrial fraction.  The resulting supernatant was further
centrifuged at 105,000×g for 45 min at 4 °C to sediment microsomes; the supernatant was
used as the cytosolic fraction.  Microsomal pellet was resuspended in a small volume of
the homogenate solution described above.  These fractions were stored at -80 °C until
assay.  Protein concentration was measured by the method of Lowry et al. (1951) using
bovine serum albumin as a standard.
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2.6 Assays of enzyme activities
Glucose-6-phsphate dehydrogenase (G6PDH, EC 1.1.1.49); The activity of
G6PDH was measured as described by Zakim and Donal (1973).  The reaction solution
contained 0.32 M Tris-HCl (pH 7.6), 50 mM MgCl2, 66 mM glucose-6-phosphate, 24 mM
NADP+, and 1 unit of 6-phosphogluconate dehydrogenase.  The reaction solution was
preincubated at 27 °C, and the reaction was initiated by adding the microsome fraction (250
µg protein) in a final assay volume of 3.0 mL at 27 °C for 2 min.  The absorbance was
determined at 340 nm.  G6PDH activity was expressed as nanomole of enzyme capable
of producing NADPH/min/mg protein.
 Malic enzyme (EC 1.1.1.40); The activity of malic enzyme was determined as
reported by Ochoa et al. (1948).  The reaction solution contained 0.4 M triethanolamine
(pH 7.4), 30 mM malic acid, 0.12 M MnCl2, and 3.4 mM NADP
+.  The reaction solution
was preincubated at 27 °C, and the reaction was initiated by adding the microsome fraction
(250 µg protein) in a final assay volume of 3.0 mL at 27 °C for 2 min.  The absorbance
was determined at 340 nm. Malic enzyme activity was expressed as nanomole of enzyme
capable of producing NADPH/min/mg protein.
Phosphatidate phosphohydrolase (PAP, EC 3.1.3.4); The activity of PAP was
assayed by the method of Possmayer and Walton with a slight modification (Walton, 1985).
The reaction mixtures contained 0.05 M Tris-HCl (pH 7.0), 1 mM L-α-phosphatidate, and
1 mM phosphatidylcholine liposomes suspended in 1.55 M sodium chloride, in the
presence of 1.25 mM magnesium sulfate, and 50 to 100 µg of liver enzyme protein in a
final assay volume of 0.2 mL.  The mixture was incubated for 15 min at 37 °C and
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reaction was terminated by the addition of 0.8 mL of a solution containing 0.13 % sodium
dodecyl sulfate, 1.25 % ascorbic acid, 0.32 % ammonium molybdate-4H2O, and 0.75 N
H2SO4.  The liberated inorganic phosphate was measured.  The phosphomolybdate color
was developed at 45 °C for 20 min and the absorbance was measured at 820 nm.  Non
enzymatic phosphate release was determined by inactivating the enzymes by boiling for
1 min without substrate.  The enzyme activity expressed as nanomole in one minute per
mg protein.
Diacylglycerol acyltransferase (DGAT, EC 2.3.1.20); The activity of DGAT was
measured as described by Coleman and Cao (1976).  In brief, the reaction mixture
contained 350 µL of 175 mM Tris-HCl (pH 8.0), 8 mM MgCl2, 30 mM [1-14C] palmitoyl-
CoA (specific activity 2.11 MBq /µM), 1mg/mL fatty acid free bovine serum albumin, and
50 µL of 125 mM 1,2-diacylglycerol dissolved in absolute ethanol were employed.  The
reaction was initiated by adding 100 µL of liver microsome or adipose tissue homogenate
(20/50 µg of protein) and blending on a vortex mixer.  The reaction was terminated after
10 minutes by adding 3.75 mL of 2-propanol/heptane/H2O (80:20:1, v/v/v).  After 5 min,
2.5 mL of heptane and 1.25 mL of water were added to the reaction mixture and the tubes
were blended on a vortex mixer and centrifuged at 3000 rpm for 5 min.  One mL of
solution from the heptane layer was transferred into scintillation counting vial.
Radioactivity was measured using a liquid scintillation counter (Wallic system 1410,
Pharmacia, Uppsala, Sweden).
2.7 Statistical analyses
Each value is presented as means ± SE.  Data were analyzed by one-way
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ANOVA, all differences being inspected by Duncan s new multiple-range test (Duncan,
1955).  A difference was considered significant at p < 0.05.
3.  RESULTS
3.1 Effects of dietary onion extract on body weight gain, food intake, and liver and white
adipose tissue weights
Body weight gain, food intake and tissues weights in rats fed the cholesterol-
enriched atherogenic diets supplemented with or without onion extract (0.4 and 1.2 %) are
shown in Table 2-2.  There was no difference in final body weight and food intake among
the groups.  However, liver weights were decreased significantly in rats fed both diets
supplemented with onion extract.
Table 2-3 shows the peritoneal and epididymal adipose tissue weights after
administering onion diet.  Adipose tissue weights tended to reduce by administering onion
extract and lowered significantly at 0.4 % onion group.
3.2 Effects of dietary onion extract on concentrations of serum lipids and glucose
TAG concentration in the serum was lower dose-dependent manner in both onion
diets compared to the control diet.  The concentrations of cholesterol, phospholipid and
free fatty acids in the serum were comparable among the groups, although 0.4 % onion
group tended to reduce the levels compared to the other two groups.  The serum
concentration of glucose was not altered by the supplementation of onion extract (Table
2-4).
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3.3 Effects of dietary onion extract on the concentrations of liver lipids
There were no significant differences in the concentrations of hepatic TAG,
phospholipid, and cholesterol, although hepatic TAG content per gram tissues tended to
higher in both onion groups (Table 2-5).  This may be in part associated with the decrease
in liver weight or the decrease in serum TAG secretion from the liver in onion-fed rats.
3.4 Effects of dietary onion extract on the enzyme activities involved in fatty acid and
TAG syntheses
Hepatic G6PDH and PAP activities were comparable among the three groups.
Hepatic malic enzyme activity was comparable between the control and 1.2 % onion
groups, but lowered in the 0.4 % onion group compared to the control group.  DGAT
activity is higher in the 1.2 % onion group compared to the other groups (Table 2-6).
4.  DISCUSSION
We demonstrated in the present study that onion extract had hypotriglyceridemic
activity and anti-obesity property in the animals fed the atherogenic diets.  This is in
agreement with the result of Babu and Srinivasan who reported that onion alleviated
hypertriglyceridemia in experimental diabetic rats, although they did not found any effect
of onion on normolipidemic rats (1997).
In general, the concentration of TAG in the serum is regulated by the rate of TAG
synthesis and fatty acid oxidation, and VLDL assembly in the liver and peripheral
lipoprotein lipase activity which catalyzes the hydrolysis of TAG to fatty acid and glycerol
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(Schulz, 1991).  To understand the underlying mechanisms by which onion reduces serum
TAG level, hepatic TAG content and enzyme activities involved in TAG and fatty acid
syntheses were measured.  However, we found no change in hepatic TAG level after
administering onion.  In addition, we did not find any consistent effects of onion extract
on malic enzyme and G6PDH, both of which catalyze NADPH formation for fatty acid
synthesis.  Furthermore, there was no significant consistent change in hepatic PAP and
DGAT activities by administering onion (Table 2-6).  Taken together, it is concluded that
supplementation of onion extract to the atherogenic diet lower serum TAG concentration
without affecting TAG synthesis in the liver.
It is postulated that dietary onion and garlic have hypocholesterolemic effects
(Sheela et al., 1995), however, no effects on cholesterol concentration in the serum and
liver were observed.  In addition, there was no difference in serum glucose and free fatty
acid levels.  It suggests that onion extract used in this experiment might be no influence
on diabetic disorder.  To further clarify this point, measurement of serum insulin level
should be required.
Dietary onion leads to reduce serum TAG level, in spite of the no significant
change in hepatic lipid content and lipid synthesis.  We hypothesize that onion
components might inhibit the assembly and secretion of apoB100-containing lipoproteins
in the liver.  It is believed that assembly of apoB100-containing lipoprotein is regulated
by lipid availability, apoB100 metabolism, and MTP activity.  Recent report indicates that
the inhibition of hepatic MTP reduces the serum lipid levels and induces the regression of
atherosclerosis (Wetterau et al., 1998).  In agreement with this, we have shown that the
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administering onion component causes to reduce hepatic MTP activity and it may
associated with the lower serum TAG concentration in rats in the following Chapter.
Lipoprotein lipase activity was not determined in the present study.
It is also interesting note that dietary onion results to decrease liver weight and
white adipose tissues, although the underlying mechanisms are not apparent at present time.
As obesity is a key disease of many common diseases, onion is thought to be a beneficial
food for health.  The onion extract used in this study was prepared by the treatments with
blanching and then with cellulase and glutaminase.  This procedure is reported to enrich
five-fold the cycloalliin content in the treated onion by Anno (2000).
In conclusion, dietary onion reduces serum TAG concentration and adipose tissue
weight in rats fed the atherogenic diet.
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　　　　　　　　 Table 2-1. Composition of experimental diet.
       Ingredients   Control      Onion  extract      
         
                                           　　   0 %              0.4 %           1.2%
      Casein                 20.0   20.0    20.0
      DL-Methionine       0.3                 0.3               0.3
      Vitamin mixture         1.0                 1.0               1.0
      Mineral mixture       4.0                 4.0              4.0
      Cellulose                   2.0                 2.0               2.0
      α-Corn starch     15.0               15.0             15.0
      Choline bitartrate       0.2                 0.2               0.2
      Cholesterol       0.5                 0.5               0.5
      Sodium cholate       0.125     0.125   0.125
      Fat     Beef tallow       5.0                 5.0               5.0  
                Corn oil       5.0     5.0               5.0
      Sucrose                 43.875   43.475 43.675   
      Dextrin                        3.0                 3.0                 3.0  
                  Onion extract       0.0                 0.4               1.2
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 Table 2-2. Effect of dietary onion extract on the growth performance and the food
          intake.
    Four-week-aged SD male rats fed the semipurified diets supplemented without
    (control) or with onion extract at the levels of either 0.4 % or 1.2 % for two weeks.
    Values are expressed as mean ± SE of six in each groups. Values with different
    letters are significantly different at p < 0.05.
   Groups 　　　Control     　  Onion  extract
　　
                          0 %                 0.1 %         0.3 %
Body weight (g)
 Initial 　　150.7±2.9　　　150.9±2.8 　 149.8±3.1
 Final 　　261.4±6.9   259.6±4.8 　 254.0±5.9    
Liver weight
             total (g)　    15.8±0.6a           13.9±0.4b       13.9±0.5b    
(g/100g B.W.)             6.1±0.2a             5.4±0.2b         5.5±0.2b 
Food intake
            (g/day)           19.9±0.7    19.2±0.4        19.2±0.4
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         Table 2-3. Effect of dietary onion extract on adipose tissue weight.
        Four-week-aged SD male rats fed the semipurified diets supplemented
        without (control) or with onion extract at the levels of either 0.4 % or 1.2 %
　　　　for two weeks. Values are expressed as mean ± SE of six in each groups.
　　　　Values with different letters are significantly different at p < 0.05.
       Groups             Control        Onion extract
                                                                    
                                                    0 %                0.4 %               1.2 %
 
                                                                 (g)
      　　 Perirenal                   1.62±0.20a     1.07±0.14b      1.21±0.14a  
       　　Epididymal               1.81±0.27      1.40±0.08        1.42±0.14 
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         Table 2-4. Effect of dietary onion extract on serum metabolites.
        Four-week-aged SD male rats fed the semipurified diets supplemented
        without (control) or with onion extract at the levels of either 0.4 % or 1.2 %
　　　　for two weeks. Values are expressed as mean ± SE of six in each groups.
　　　　Values with different letters are significantly different at p < 0.05.
       Groups             Control        Onion extract
                                                                    
                                                  0 %                  0.4 %                  1.2 %
 
                                                           (mg/dL)
       Triacylglycerol          237.6±30.0a      195.5±31.3a       147.6±23.5b
       Phospholipid             180.1±14.1        169.9±11.3        183.2±16.6  
       Cholesterol                139.0±21.6        116.8±10.3        141.3±11.3
       Glucose                     137.1±12.8        138.2±6.7          129.0±11.0  
                                                                       (µEq/L)
       Free Fatty Acid          663.2±48.3        627.3±61.3        661.8±40.3
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      Table 2-5. Effect of dietary onion extract on the hepatic lipid levels.
     Four-week-aged SD male rats fed the semipurified diets supplemented
     without (control) or with onion extract at the levels of either 0.4 % or 1.2 %
　　 for two weeks. Values are expressed as mean ± SE of six in each groups.
     *Abbreviation: PAP: phosphatidate phosphohydrolase,
      G6PDH: glucose-6-phosphate dehydrogenase, ME: malic enzyme,
      DGAT: diacylglycerol acyltransferase.
       Groups             Control        Onion extract
                                                                    
                                                    0 %                0.4 %               1.2 %
 
                                                        (mg/g liver)
       Triacylglycerol              71.2±2.4         75.4±6.4          75.3±11.5
       Phospholipid                  28.4±1.9         29.4±1.1          29.4±1.1  
       Cholesterol                     37.0±1.5         39.0±3.6          40.4±2.1
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    Table 2-6. Effect of dietary onion extract on the activities of hepatic enzymes.
      Four-week-aged SD male rats fed the semipurified diets supplemented
      without (control) or with onion extract at the levels of either 0.4 % or 1.2 %
　　　for two weeks. Values are expressed as mean ± SE of six in each groups.
　　　Values with different letters are significantly different at p < 0.05.
       Groups             Control        Onion extract
                                                                    
                                                    0 %                0.4 %               1.2 %
 
                                                (nmol/min/mg protein)
      G6PDH                        116.9±4.8         104.7±4.9        106.3±6.0
      PAP                                  9.5±0.6             9.0±1.0            9.7±0.4
      ME                                 40.6± 3.2a         33.7±2.0b         37.9±4.9a     
      DGAT                              2.9±0.3a            2.8±0.3a           4.1±0.4b
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CHAPTER III
Effects of cycloalliin on lipid metabolism in rats and
in HepG2 cells
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Part 1. Effects of dietary cycloalliin on lipid metabolism and the
related enzyme activities in rats fed cholesterol-enriched diets
1.  INTRODUCTION
We demonstrated in Chapter II that dietary onion extract had a
hypotriglyceridemic effect, accompanying with decreases in adipose tissue weights in the
rat.  It is well known that onion and garlic contain a variety of sulfur-containing
compounds (Block, 1992).  Cycloalliin is a main sulfur-containing imino compound with
a cyclic structure and its content is markedly increased in onion after cooking, which
accounts for about 50 % of all sulfur-containing compounds (Ueda et al., 1994).  It is
suggested that by heating-treatment, S-propenyl-cysteine sulfoxide and other sulfur-
containing compounds in onion appear to form a stable cyclic structure, cycloalliin (Fig.
4).  It has been reported that cycloalliin promotes a fibrinolytic activity in the blood
(Agarwal et al., 1977).  However, little is known about other physiological activities of
this compound.  In this part, we studied the effects of dietary cycloalliin on liver and
serum lipid concentrations and on enzyme activities related to lipid metabolism in rats fed
cholesterol-enriched diets.
2.  MATERIALS AND METHODS
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2.1 Experimental material and reagents
Cycloalliin (cycloalliin hydrochloride monohydrate) was supplied by Nippon
Shinyaku (Kyoto, Japan).  All other chemicals and reagents were of special grade
available.
2.2 Experimental animals and diets
Four-week-aged male SD-strain rats (125-135 g) were obtained from Kyudo
(Tosu, Japan) and maintained in an individual stainless-meshed cage on a temperature-
controlled room (24 °C) with a 12 h light/dark cycle.  They were divided into three groups
with equal body weight (6 rats in each group) after rearing with a stock pellet chow (CE-2,
CLEA, Tokyo, Japan) for 7 days.  Control group was given the semipurified atherogenic
diet that contains 0.5 % cholesterol and 0.125 % sodium cholate.  The remaining two
groups were fed the cholesterol-enriched diets supplemented with either 0.1 % or 0.3 %
of cycloalliin.  The composition of experimental diets is presented in Table 3-1-1.  The
animals had free access to the diet and water.  Food intake was recorded everyday, and
body weight was recorded every other day during the experimental period.  After 2 weeks,
they were fasted for 5 h, and then blood was collected from vena cava and the liver was
excised under diethyl ether-anesthesia.  The study was approved by Saga University
Institutional Animal Care and Use Committee.
2.3 Preparation of liver subcellular fractions.
Liver homogenates and subcellular fractions were prepared as described in
Chapter II.
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2.4 Lipid analyses
Serum and hepatic lipids were measured as described in Chapter II.
2.5 Assays of TAG synthetic enzymes in the liver
The activities of phosphatidate phosphohydrolase (PAP, EC 3.1.3.4) , glucose-6-
phosphate dehydrogenase (G6PDH, EC 1.1.1.49), and malic enzyme (EC 1.1.1.40) were
determined as described in Chapter II.
2.6 Assay of MTP activity
Microsomal TAG transfer protein (MTP) activity was determined by measuring
the rate of transfer of radiolabeled TAG between two populations of unilamellar vesicles
by the method of Wetterau et al. (1986), with a slight modification.  In brief, assay buffer
was prepared in 15 mM Tris-HCl (pH 7.4), 35 mM NaCl, 0.02 % sodium azide, and 1 mM
EDTA (designated as the assay buffer) by bath sonication in a screwcapped tube under the
nitrogen gas.  Donor vesicle contained 35 nM of phosphatidylcholine (PC), 0.175 nM of
TAG, 18.5 kBq [14C]triolein, and 0.1 % butyrated hydroxytoluene.  Acceptor vesicle
contained 175 nM of PC, 0.875 nM of TAG, 8.8 nM of cardiolipin, and 0.1 % butyrated
hydroxytoluene.  The final reaction mixture in a total volume of 1.0 mL contained 20 µL
of donor vesicle, 100 µL of acceptor vesicle, 100 µL of 5 % BSA, microsomal sample
(protein content: 50 µg/100 µL), and assay buffer.  The reaction was terminated by adding
0.5 mL DEAE-cellulose in 1 volume of assay buffer.  The mixture was agitated for 1 min,
and then DEAE-cellulose, which adsorbed acceptor vesicle, was sedimented by
centrifugation at 3000 rpm for 3 min at room temperature.  The radioactivity in an aliquot
of the supernatant was determined.  Transfer activity was calculated as follows: percent
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of transfer activity = dpm ([blank donor vesicle fraction] minus [sample donor vesicle
fraction])/dpm (blank donor vesicle fraction)×100.
2.7 Statistical analyses
Each value is presented as means ± SE.  Data were analyzed by one-way
ANOVA, all differences being inspected by Duncan s new multiple-range test (Duncan,
1955).  A difference was considered significant at p < 0.05.
3. RESULTS
3.1 Effects of cycloalliin on body weight, food intake, and liver weight
When rats were fed high cholesterol diets supplemented with cycloalliin at 0.1 %
and 0.3 % levels for 2 weeks, there were no significant differences in body weight gain and
food intake among the groups, as shown in Table 3-1-2.  In addition, supplementation of
0.1 % and 0.3 % cycloalliin to the high cholesterol diet did not cause untoward effect on
liver weight (Table 3-1-2).
3.2 Effects of cycloalliin on serum and liver lipid levels in rats
 The supplementation of cycloalliin at the levels of  0.1 % and 0.3 % to the
cholesterol-enriched diets as compared to those without cycloalliin caused 39 % and
44 % reductions in the concentration of serum TAG, respectively (Fig. 5), indicating a
dose-dependent reduction of serum TAG levels by cycloalliin.  In contrast, cycloalliin had
no effects on the concentrations of total- and HDL-cholesterol in the serum, although the
concentration of cholesterol ester in the serum showed slight tendency to decrease (Fig.
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6).  Dietary cycloalliin exerted no significant effects on hepatic concentrations of TAG,
cholesterol and phospholipids, although there was a slight tendency to increase in TAG and
phospholipid contents (Table 3-1-3).
3.3 Effect of dietary cycloalliin on hepatic activities of PAP, malic enzyme, and G6PDH
 Figure 7 shows hepatic enzyme activities regarding TAG and fatty acid syntheses.
Neither the activity of microsomal PAP nor that of malic enzyme and G6PDH, NADPH-
generating enzyme, remained changed by feeding of 0.1 % and 0.3 % level of cycloalliin
in the diet, respectively (Fig. 7).
3.4 Effect of dietary cycloalliin MTP activity
As MTP is required for apoB-containing lipoprotein assembly and secretion,
the effect of cycloalliin on hepatic MTP activity was measured in rats fed on cholesterol-
enriched diets.  As shown in Fig. 8, the MTP activity in rats fed cycloalliin was
significantly lower than that of control rats; the lowering efficacy of dietary cycloalliin was
a dose-dependent manner.
4. DISCUSSION
When growing male SD-rats were fed cholesterol-enriched atherogenic diets
supplemented with or without cycloalliin for 2 weeks, no change in growth parameters such
as body weight gain and food intake was found (Table 3-1-2), suggesting that cycloalliin,
at least up to the 0.3 % dietary level, had no deleterious effect.  We demonstrated in the
present studies that feeding of cycloalliin, a cyclic sulfur imino acid found in onion, caused
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a marked reduction in the concentration of serum TAG in rats fed cholesterol-enriched
diets.  As hypertirglyceridemia is reported to be a risk factor of atherosclerosis (Brewer,
1999), cycloalliin in cooked onion is a beneficial ingredient for ameliorating lipid disorders
caused by westernization of dietary habits.  In the cycloalliin-fed rats, the reduced
concentration of serum TAG was almost comparable at the levels of  0.1 % and 0.3 %,
suggesting 0.1 % supplementation is enough to cause a marked reduction of serum TAG.
In contrast, serum cholesterol and phospholipid levels remained unchanged following
feeding of cycloalliin for 2 weeks.  On the other hand, there was no significant difference
in the concentration of hepatic lipids.  Thus, the effects of dietary cycloalliin are mostly
observed on serum TAG component, but not other lipid compositions.  Liver is central
organ regulating lipid and lipoprotein metabolism.  Furthermore, in general, serum lipid
levels are closely associated with an altered lipid metabolism in the liver (Angelin, 1993).
 In this context, we measured hepatic lipid concentration and the relating enzyme
activities involved in TAG biosynthesis.  Dietary cycloalliin produced no remarkable
effects on hepatic TAG content and other lipid parameters (Table 3-1-3). Hepatic TAG
content is regulated by TAG biosynthesis, secretion of TAG into blood stream in the form
of lipoproteins, or degradation of fatty acid in mitochondrial beta-oxidation (Gibbsons,
2001).  In this experiment, we measured several marker enzyme activities for TAG
synthesis such as microsomal PAP, which is a key enzyme for TAG synthesis (Fremont,
1996), and DGAT in the liver (Waggoner, 1995).  In addition, the enzyme activities
relating de novo fatty acid synthesis such as malic enzyme and G6PDH, which are the
enzymes generating NADPH, was also determined.  However, we were unable to find any
33
alterations in the activities of PAP, malic enzyme, and G6PDH in the livers of rats fed diets
containing cycloalliin as compared to the control group.  These observations suggest that
the reduced concentration of serum TAG by dietary cycloalliin is not attributable to an
alteration of hepatic TAG and fatty acid syntheses, but rather with other steps such as
lipoprotein assembly or secretion in the liver.
 It is known that hepatic VLDL secretion is positively related to various steps such
as lipid synthesis, apoB100 production, and MTP activity (Jamil, 1998); the latest enzyme
is a soluble protein that is localized in the lumen of the endoplasmic reticulum in the cells
of liver and small intestines, and this protein is recently reported to be essential for
transporting the newly synthesized lipid components to the site for forming apoB100-
containig lipoproteins, since depletion of MTP activity has been reported to cause
abetalipoproteinemia (Wetterau et al., 1992).  It was also observed that inhibition of
VLDL assembly by MTP inhibitor causes fatty liver (Wang et al., 1999).  We are
therefore focusing whether feeding of cycloalliin alters hepatic MTP activity.  Since
dietary cycloalliin significantly decreased serum TAG concentration without altering TAG
synthesis and its concentration in the liver, the remaining possible factor is whether MTP
activity is responded negatively (Gordon et al., 1996).  Consistent with our assumptions,
we demonstrated for the first time that dietary cycloalliin inhibits MTP activity in the liver.
In addition, the decreased concentration of serum TAG appeared to relate to the decrease
in the MTP activity in the liver, so we further analyzed the relationship between
concentration of TAG in the serum and MTP activity by using linear regression analysis.
A very close negative correlation was evident between these two parameters (r = 0.925,
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p < 0.05, Fig. 8).  Therefore, the cycloalliin-dependent decrease in MTP activity leads to
an impairment of apoB100-containing lipoprotein assembly.  A slight increase in hepatic
TAG concentration by cycloalliin feeding favors for the assumption, although more detailed
mechanism by which cycloalliin inhibits MTP activity remains to be determined.
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       Fig.4. Chemical structure and the process of formation of cycloalliin
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                Table 3-1-1. Composition of experimental diet.
       Ingredients   Control          Cycloalliin
               
                                           　　   0 %              0.1 %           0.3 %
      Casein                 20.0   20.0    20.0
      DL-Methionine       0.3                 0.3               0.3
      Vitamin mixture         1.0                 1.0               1.0
      Mineral mixture       4.0                 4.0              4.0
      Cellulose                   5.0                 5.0               5.0
     α-Corn starch     15.0               15.0             15.0
      Choline bitartrate       0.2                 0.2               0.2
      Cholesterol       0.5                 0.5               0.5
      Sodium cholate       0.125     0.125   0.125
      Fat     Beef tallow       5.0                 5.0               5.0  
                Corn oil       5.0     5.0               5.0
      Sucrose                 43.875   43.775 43.575    
      Cycloalliin*       0.0                 0.1               0.3
 
* Cycloalliin was supplemented in the form of cycloalliin   
   hydrochloride monohydrate.
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    Table 3-1-2. Effect of dietary cycloalliin on the growth performance and the food       
              intake.
    Four-week-aged SD male rats fed the semipurified diets supplemented without
    (control) or with cycloalliin at the levels of either 0.1 % or 0.3 % for two weeks.
    Values are expressed as mean ± SE of six in each groups.
   Groups 　　　Control     　　 Cycloalliin
　　
                          0 %                 0.1 %         0.3 %
Body weight (g)
 Initial 　　130.1±4.1 133.1±2.9 　 130.2±2.8    
             Final 　　268.2±5.2 268.1±2.9 　 266.8±3.5    
Liver weight
             total (g)　    17.4±0.4   17.2±0.6 　   17.1±0.4
    (g/100g B.W.)         6.5±0.1     6.4±0.2          6.4±0.1
 Food intake
            (g/day)           20.0±0.5   19.7±0.3        20.6±0.4
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         Fig.5. Effect of dietary cycloalliin on the serum TAG concentration.
               Four-week-aged SD male rats fed the semipurified diets
               supplemented without (control) or with cycloalliin at the levels
               of either 0.1 % or 0.3 % for two weeks. Values are expressed as
               mean ± SE of six in each groups. Values with different letters
               are significantly different at p < 0.05.
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 Fig.6. Effect of dietary cycloalliin on the serum lipid levels.
                  Four-week-aged SD male rats fed the semipurified diets
                  supplemented without (control) or with cycloalliin at the
                  levels of either 0.1 % or 0.3 % for two weeks. Values are
                  expressed as mean ± SE of six in each groups. Values with
                  different letters are significantly different at p < 0.05.
                  *Abbreviation: PL; phospholipid, T-Chol; total cholesterol,
                  CE; cholesterol ester, HDL-chol; high density lipoprotein-
                  cholesterol.
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         Table 3-1-3. Effect of dietary cycloalliin on the hepatic lipid levels.
    Four-week-aged SD male rats fed the semipurified diets supplemented without
    (control) or with cycloalliin at the levels of either 0.1 % or 0.3 % for two weeks.
    Values are expressed as mean ± SE of six in each groups.
       Groups             Control          Cycloalliin
                                                                    
                                                    0 %                0.1 %              0.3 %
 
                                                        (mg/g liver)
       Triacylglycerol              62.2±2.9         72.6±4.5          77.8±6.0
       Phospholipid                  21.9±1.9         25.9±0.8          24.2±1.9  
       Cholesterol                     37.1±4.6         40.6±3.3          36.8±2.7
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    Fig.7. Effect of dietary cycloalliin on the activities of hepatic lipogenic enzymes.
  Four-week-aged SD male rats fed the semipurified diets supplemented
         without (control) or with cycloalliin at the levels of either 0.1 % or 0.3 %
         for two weeks. Values are expressed as mean ± SE of six in each groups.
         Values with different letters are significantly different at p < 0.05.
         *Abbreviation: PAP: phosphatidate phosphohydrolase, G6PDH: glucose-6-      
         phosphate dehydrogenase, ME: malic enzyme.
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             Fig. 8. Effect of dietary cycloalliin on the MTP activity.
                      Four-week-aged SD male rats fed the semipurified diets       
                  supplemented without (control) or with cycloalliin at the
                  levels of either 0.1 % or 0.3 % for two weeks. Values
                  are expressed as mean ± SE of six in each groups.
                  Values with different letters are significantly different at
                  p < 0.05. *MTP: microsomal TAG transfer protein.
10864
100
200
300
400
0
2
4
6
8
10
12
r=0.925
    0             0.1           0.3 
Cycloalliin ( % )
       (% of TAG transfer activity)
a
b
b
MTP activity Correlation
Serum TAG concentration (mg/dL)
MTP activity (% of TAG transfer activity)
43
Part 2. Effects of cycloalliin on lipid and apoB100-containing
lipoprotein metabolism in HepG2 cells
1.  INTRODUCTION
In Part 1 of this chapter, we have demonstrated that feeding of cycloalliin, main
component of sulfur-containing compound of cooked onion, exhibits a hypotriglyceridemic
action.  This reduction was, in part, due to a reduced activity of hepatic MTP without
altering the synthesis of TAG in the liver of rats.  In this part, to understand a detailed
mechanism responsible for the observed reduction of serum TAG level, an effect of
cycloalliin on the lipoprotein metabolism in HepG2 cell was studied.  HepG2 cells are
derived from human hepatoblastoma and retains many original functions of normal human
hepatocytes (Sandra, 1995).  It is widely used to study the regulation of lipid and
lipoprotein metabolism (Erickson & Fielding, 1995; Yanagita et al., 1995,1996,1999).  In
this part, we investigate whether an addition of cycloalliin to the culture medium of HepG2
cells alters the secretion of apoB100 and newly synthesized TAG from the liver.
2.  MATERIALS AND METHODS
2.1 Experimental material and reagents
Cycloalliin (cycloalliin hydrochloride monohydrate) was supplied by Nippon
Shinyaku (Kyoto, Japan).  HepG2 cells were obtained from Riken Cell Bank (Tsukuba,
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Japan).  Dulbecco s Modified Eagle medium (DMEM) and trypsin were provided from
Gibco (Grand Island, NY, USA).  Fetal calf serum (FCS) was obtained from Sigma (St.
Louis, MO, USA), and penicillin and streptomycin were products of Meiji Seika Kaisha,
Ltd. (Tokyo, Japan).  Lipoprotein-deficient serum (LPDS) was purchased from Sigma (St.
Louis, MO, USA).  [14C]Acetate (specific activity: 2.07 MBq/µM) was purchased from
Amersham, Inc. (Buckinghamshire, England).  Scintillation cocktail (Sintisol Ex-H) was
purchased from Dojin Chemical Company (Kumamoto, Japan).
2.2 HepG2 cell culture
 HepG2 cells were preincubated in DMEM supplemented with 10 % FCS,
penicillin (100 µg/mL), and streptomycin (100 µg/mL) at 37 °C in air containing 5 % (v/v)
CO2 to keep the pH 7.4 constant.  The culture medium was renewed with fresh medium
every third day.  Semiconfluent cells on 24-well cell culture plate were washed twice with
DMEM, and cultured for 24 h in the medium containing 10 % LPDS and 1 mM oleate with
added cycloalliin.  The cells cultured in the medium in the absence of cycloalliin were
used as control.  [14C]Acetate (18.5 kBq) was added into the medium at the beginning of
experiment.  After incubation, cells and medium were harvested separately.  After
removal of culture medium, cells were washed twice with chilled phosphate buffered-saline
(PBS), and then 1 mL of PBS was added into each well.  The cells were collected,
transferred into a rubber policeman, and frozen at -80 °C until analysis.
2.3 Preparation of experimental medium
 Cycloalliin dissolved in dimethyl sulfoxide (DMSO) was diluted in 10 % LPDS-
DMEM.  Final concentration of cycloalliin in the medium was 1 µM or 100 µM.  All
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experimental mediums were sterilized by passing through a 0.45 µm Millipore R filter.
2.4 Determination of cellular protein concentration
 Cells were disrupted with a sonicator (sonifier 250TM, Branson Ultradonid Co.,
Connecticut, USA), and analyzed for cellular protein concentration by using the BCA
protein assay kit purchased from PIERCE (Rockford, IL, USA) (Smith et al., 1985).
2.5 Cell viability assay
 MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay was
performed as a parameter of cell viability as reported by Sladowski et al. (1993), since it
is known that HepG2 cells stained with MTT reagent indicate functionally normal.  In
brief, the cells were precultured in medium on a 96-well plate, and then 20 µL of MTT
solution (5 mg/mL PBS) was added into each well.  The cells were incubated for another
3 h, and then the reaction was terminated by addition of 150 µL of mixture (dimetyl
sulfoxide:ethanol=1:1, v/v) following removal of medium.  After shaking for 15 min, the
absorbance was determined at 570 nm by the 96-well plate reader (CS-9300 PC, Simadzu
Co., Ltd., Kyoto, Japan).
2.6 Accumulation of apoB100 in the medium by HepG2 cells
 ApoB100 concentration in the medium was measured by a double antibody
enzyme-linked immunosorbent assay (ELISA) as reported by Young et al. (1986).  In
brief, the medium collected was diluted 200-fold with PBS, and transferred to the 96-well
plates which were coated with coating buffer containing 15 mM Na2CO3, 31 mM NaHCO3,
pH 9.6, and 17.3 mg/L of rabbit anti-human IgG; this was maintained at 37 °C for 2 h, and
then each well was incubated with 0.1 mL of BSA containing 0.5 % sodium azide for
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another 2 h.  The wells were washed three times with PBS containing 0.5 mL/L of Tween
20.  Sample solution was added to the wells, and incubated at 4 °C for 16 h.  After
washing, 0.1 mL of phenylenediamine substrate solution was added to the wells and
maintained at 25 °C for 30 min.  The reaction was terminated by adding 50 µL of 4.5 M
H2SO4, and the absorbance was determined in the individual well at 492 nm by the 96-well
plate reader.
 2.7 TAG syntheses and their secretion into medium
 The radioactivity of medium lipids were measured by a liquid scintillation counter
(Wallic system 1410, Pharmacia, Sweden) as reported by Yanagita et al. (1995), following
the extraction and purification of total lipids by the method of Bligh and Dyer (1959).
Neutral lipid subclasses were separated by thin-layer chromatography using a precoated
silica gel G plate developed with a solvent mixture of petroleum ether:diethylether:glacial
acetic acid (80:20:1, v/v/v).  Autoradiography of the plate was performed with an imaging
plate and a BAS 1000 image analyzer (Fuji Photo Film Co., Ltd. Kanagawa, Japan).
2.8 Statistical analyses
Each value is presented as means ± SE.  Data were analyzed by one-way
ANOVA, all differences being inspected by Duncan s new multiple-range test (Duncan,
1955).  A difference was considered significant at p < 0.05.  Student s t-test (Fisher,
1970) was also used in some comparison.
3. RESULTS
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3.1 HepG2 cell viability assay
 HepG2 cells were cultured up to 24 h in the medium supplemented with or without
cycloalliin.  Final cycloalliin concentration was 1 µM or 100 µM.  No significant change
was noted in the concentration of intracellular protein following incubation with cycloalliin
up to 100 µM (Fig.9).  Cell viability also remained unchanged among the groups (Fig.
9).  These results suggest that cycloalliin had no significant effect on cell viability.
3.2 Secretion of apoB100 by HepG2 cells
 Figure 10 shows the apoB100 concentration in the medium after incubation with
cycloalliin for 24 h.  Cycloalliin treatment at the concentration of 1 µM as compared to
the control caused a 24 % reduction in the accumulation of apoB100.  The increasing
amounts of cycloalliin from 1 µM to 100 µM had no further influence on apoB100
production, suggesting that treatment of 1 µM cycloalliin with HepG2 cells caused
maximum rate of inhibition on apoB100 production (Fig. 10).
3.3 Incorporation of [14C]acetate into medium TAG
 Incorporation of [14C]acetate into medium TAG was measured after 24 h
incubation.  Incorporation of [14C]acetate into medium lipids was more marked into TAG
than into both cholesterol ester and free cholesterol (data not shown).  These results
suggest that acetate added at the beginning of experiment was taken up by hepatocyte, and
was secreted as lipids to the medium.  Under this condition, cycloalliin treatment
markedly decreased the secretion of [14C]TAG (Fig. 12).
4. DISCUSSION
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 The present study focused on the effect of cycloalliin on TAG metabolism and
apoB100 production in HepG2 cells.  Incubation of the cells with cycloalliin at the
concentration up to 100 µM had no effect on cell viability and cellular protein
concentration compared with no added cycloalliin (Fig. 9).  These results indicate that
cycloalliin had no toxic effect on cell function under the present experimental conditions.
Since apoB100 is a main protein component of lipoproteins, we measured apoB100
concentration in the medium.  It was found that apoB100 production was decreased by
the treatment of cycloalliin at the concentration of 1 µM, suggesting the decrease in the
inhibition of VLDL assembly and synthesis.  Furthermore, we examined the effect of
cycloalliin on the secretion of newly synthesized TAG from the HepG2 cells by using
radiolabeled precursor, [14C]acetate.  Acetate was employed for fatty acid synthesis and
then TAG synthesis.  In this condition, cycloalliin apparently reduced the secretion of
labeled TAG level (Fig. 12).  Intracellular apoB100 metabolism is regulated by the
component of lipids, especially TAG or cholesteryl ester (Roger, 1996).  The present
observations suggest a high positive correlation between TAG and apoB100 concentrations
in the medium (data not shown).  Indeed, the reduction of apoB100 concentration in the
medium was correlated well with the decrease in the concentration of TAG in the medium
(Fig. 11).  Considering together with these results from in vivo experiment with
hypercholesterolemic rats and HepG2 cells in vitro, mechanism(s) responsible for
hypotriglyceridemic action of dietary cycloalliin might be chain events in the liver as
follows: a) decrease in transfer of TAG to the site for binding with apoB100 due to
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decreased MTP activity; b) decreased synthesis and secretion of apoB100-containing
lipoproteins; c) decreased the concentration of TAG in the serum.
 In conclusion, the results presented in this chapter demonstrated for the first time
that cycloalliin could reduce the concentration of serum TAG, and this hypotriglyceridemic
action was, in part, due to the coordinated reduction of hepatic MTP activity and apoB100-
containing lipoprotein assembly in the liver.
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        Fig.9. Effect of cycloalliin on the cytotoxicity and the cell proliferation.
      Semiconfluent HepG2 cells were preincubated in the DMEM
      containing 10 % LPDS (basal medium) and 0.5 mM oleate
      for 24 h. Then, the cells were incubated in the basal medium
      containing 1 or 100 µM) of cycloalliin for another 24 h.
      Data are expressed as a percentage of the control and represent
      means ± SE of 4 samples.
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    Fig.10. Effect of cycloalliin on apolipoprotein B100 secretion into the medium.
   Semiconfluent HepG2 cells were preincubated in the DMEM
   containing 10 % LPDS (basal medium) and 0.5 mM oleate for 24 h.
   Then, the cells were incubated in the basal medium containing 1 or 100 µM    
   of cycloalliin for another 24 h. Data are expressed as a percentage of the
          control and represent means ± SE of 4 samples.
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     Fig.11. Effect of cycloalliin on the concentration of TAG in the medium.
    Semiconfluent HepG2 cells were preincubated in the DMEM
    containing 10 % LPDS (basal medium) and 0.5 mM oleate
    for 24 h. Then, the cells were incubated in the basal medium
    containing 1 or 100 µM of cycloalliin for another 24 h. After
    extraction and separation by TLC, TAG was measured quantitatively
    by GLC. 15:0 TAG was used as an internal standard. Data are
    expressed as a percentage of the control and represent means ± SE
    of 4 samples. Values with different letters are significantly different
    at p < 0.05.
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     Fig12. Effect of cycloalliin on the incorporation of [14C]acetate into TAG and
           secretion into the medium.
    Semiconfluent HepG2 cells were preincubated in the DMEM containing       
    10 % LPDS (basal medium) and 0.5 mM oleate for 24 h. After
    preincubation, the cells were incubated in the medium containing 1 or 100    
    µM of cycloalliin and 18.5 kBq [14C]acetate for 24 h. The value of the    
    incorporation of [14C]acetate into TAG in untreated cells ((657 ± 74) x 10-3  
    dpm/ mg cell protein) was arbitrarily defined as 100. The value of the   
    secretion of [14C]TAG into the medium in untreated cells ((47.1 ± 2.4 ) x 10-3  
    dpm/ mg cell protein) was arbitrarily defined as 100. Data represent means
    ± SE of 4 samples. Values not sharing the same letter are significantly
    different at p < 0.05.
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CHAPTER IV
Effects of alkyl-cysteines and cysteine- and methionine-
sulfoxides on lipid and apoB100-containing lipoprotein
metabolism in HepG2 cells
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Part 1. Effects of alkyl-cysteines on lipid and apoB100-containing
lipoprotein metabolism in HepG2 cells
1.  INTRODUCTION
In the previous chapter, we demonstrated that cycloalliin, a cyclic sulfur
compound in onion, could reduce serum TAG concentration in rats fed the atherogenic diet.
In addition, we also found that the addition of cycloalliin to the culture medium of HepG2
cells caused a reduction in the secretion of TAG and apoB100.  These observations
suggest that hypotriglyceridemic action of dietary onion extract is, in part, due to
cycloalliin presented in this vegetable.  On the other hand, it has been known that onion
contains a variety of sulfur-containing compounds which are expected to have biological
activities.  However, the functions of these sulfur-containing amino acids were not
extensively studied except for the relation to specific odor.  Therefore we conducted to
examine whether naturally occurring sulfur compounds found in onion have physiological
activity.  In this part, we examine whether alkyl-cysteines, S-methyl cysteine, S-ethyl
cysteine, and S-propyl cysteine (Fig. 13) have effect on apoB100-containing lipoprotein
metabolism in human liver cells.
2. MATERIALS AND METHODS
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2.1 Experimental materials and reagents
HepG2 cells were obtained from Riken Cell Bank (Tsukuba, Japan).  [14C]Oleate
(specific activity: 2.04 MBq/µM) and [14C]acetate (specific activity: 2.07 MBq/µM) were
purchased from Amersham, Inc. (Buckinghamshire, England).  S-Methyl cysteine, S-ethyl
cysteine, and S-propyl cysteine were purchased from Sigma (St. Louis, MO, USA).
Scintillation cocktail (Sintisol Ex-H) was purchased from Dojin Chemical Company
(Kumamoto, Japan). Other chemicals used in this part were the same as those described
in the previous chapter.
2.2 HepG2 cell culture
HepG2 cells were treated with the same manner as those described in Chapter II
and used for the following experiments.
2.2.1 Experiment I
The cells were cultured for 3 and 24 h in the medium supplemented with or
without 10 µM S-propyl cysteine. [14C]Acetate (18.5 kBq) or [14C]oleate (18.5 kBq) was
added into the medium at the beginning of experiment.  After incubation, the cells and
supernatant were harvested separately, stored in a rubber policeman, and frozen at -80 °C
until analysis.
2.2.2 Experiment II
The cells were cultured for 24 h in the medium supplemented with or without one
of the cysteine derivatives, S-methyl cysteine, S-ethyl cysteine, or S-propyl cysteine, at the
concentration of 10 µM. [14C]Acetate (18.5 kBq) was added into the medium at the
beginning of the experiment, and chased as reported by Yanagita et al. (1995).  After
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incubation, the cells and the supernatants were harvested separately and frozen at -80 °C
until analysis.
2.3 Preparation of experimental medium containing cysteine derivatives
Cysteine derivatives were dissolved in PBS, and diluted in DMEM containing
1 % BSA.  All of these medium were sterilized by passing through a 0.45 µm Millipore
R filter, and subjected to cell culture experiments.
2.4 Determination of cellular protein concentration
Cells were disrupted with a sonicator (sonifier 250TM, Branson Ultradonid Co.,
Connecticut, USA) and subjected for the cellular protein concentration assay as described
in Chapter II.
2.5 Cell viability
MTT assay was performed as described in Chapter II.
2.6 Determination of secretion of apoB100 into the medium from HepG2 cells
ApoB100 concentration was measured as described in Chapter II.
2.7 Lipid synthesis and their secretion into the medium
Incorporation of [14C]acetate into cellular and medium lipids were measured as
described in Chapter II.
2.8 Statistical Analyses
Each value is presented as means ± SE.  Data were analyzed by one-way
ANOVA, all differences being inspected by Duncan s new multiple-range test (Duncan,
1955).  A difference was considered significant at p < 0.05. Student s t-test (Fisher, 1970)
was also used in some comparison.
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3. RESULTS
3.1 Effect of S-propyl cysteine on cell viability and protein concentration in HepG2 cells
As described in the previous chapter, cells stained with MTT reagent indicate the
number of cells functioned normally.  Therefore, this parameter can be used as an index
of cell viability.  S-Propyl cysteine treatment did not show any untoward effects on cell
viability when treated with S-propyl cysteine at the concentrations in the range of 10 µM
to 1000 µM (Fig. 14).  Similarly, no significant difference was noted in the cellular
protein concentration, after the 24 h-incubation of the cells with or without S-propyl
cysteines (Fig. 14).  These results therefore suggest that S-propyl cysteine at the
concentrations used in this study is not cytotoxic to HepG2 cells.
3.2 Effect of S-propyl cysteine on the secretion of apoB100 in the medium
Figure 15 shows the concentration of secreted apoB100 in the medium.
Accumulation of apoB100 in the medium was progressively increased with prolonged
incubation; at the 24 h incubation, 1.7-fold higher apoB100 concentration in the medium
was found in comparison with that for 3h.  On the other hand, addition of S-propyl
cysteine to the medium caused approximately 18-20 % reduction in apoB100 concentration
in the medium at 3 and 24h-incubation.  It clearly indicates that a S-propyl cysteine causes
the reduction in the secretion of apoB100 by HepG2 cells.
3.3 Effect of S-propyl cysteine on the incorporation of [14C]acetate into cellular and
medium TAG and cholesterol
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Incorporation of [14C]acetate into cellular and medium lipids are shown in Fig.
16.  Incorporation of [14C]acetate into cellular TAG was similar in the presence and in the
absence of S-propyl cysteine for 24 h.  However, incorporation into medium was
significantly lowered by 38 % following treatment of S-propyl cysteine (Fig. 16).  Cells
treated with S-propyl cysteine also exhibited a comparable incorporation rate of acetate
into cellular cholesterol with those untreated cells (Fig. 16).  However, accumulation of
the labeled-cholesterol in the medium was again significantly lowered by the treatment of
S-propyl cysteine.  A similar response was observed for phospholipids (data not shown).
These results suggest that S-propyl cysteine is a potent amino acid derivative to cause
inhibitory effects on lipid secretion by the liver cells.
3.4 Effect of S-propyl cysteine on the esterification of [14C]oleate to form TAG and
cholesterol ester(CE)
Figure 17 shows incorporation of exogenous substrate [14C]oleate into TAG and
CE in the HepG2 cells. Incorporation of [14C]oleate into TAG was far greater than that into
CE in the liver (Fig. 17).  It suggests that oleate supplied exogenously is taken up by the
liver, and is predominantly incorporated into TAG rather than into CE, consistent with
previous observations (Dixon et al., 1991).  In this condition, addition of S-propyl
cysteine to the medium caused 42 % and 34 % reductions in the incorporation of
[14C]oleate into cellular TAG and CE, respectively (Fig. 17).  It might suggest that S-
propyl cysteine inhibits the esterification process to form TAG and CE in hepatic cells, and
hence lead to the reduction of apoB100-containing lipoprotein secretion by the liver.
However, there may be possible other mechanism such as S-propyl cysteine added inhibits
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the transport of exogenous oleate into the cells.  It remains to clarify.
3.5 Effect of alkyl-cysteine derivatives on the accumulation of apoB100 and lipid
syntheses
In the preceding experiment, we have observed that the treatment with S-propyl
cysteine reduced accumulation of apoB100-containing lipoproteins in the medium of the
cells.  In the present study, we compared whether cysteine derivatives with various carbon
chain length such as S-methyl cysteine, S-ethyl cysteine, and S-propyl cysteine, influence
the secretion of apoB100-containing lipoproteins.  In this experiment, HepG2 cells were
incubated in the medium containing 10 µM of these cysteine derivatives.
Accumulation of apoB100 in the medium tended to decrease following treatment
of increasing carbon chain length of cysteine derivatives, and a significant reduction was
observed by the treatment of propyl-cysteine, the longest carbon chain length used (Fig.18).
This suggests that carbon chain length of cysteine derivatives is an important factor for
regulating apoB100 production in the liver.
Incorporation of the [14C]acetate into TAG and cholesterol in the medium also
tended to decrease by the treatment of these three cysteine derivatives (Fig. 19); the extent
of reduction in incorporation of the labeled TAG into the medium was 20 %, 35 %, and
36 % for S-methyl cysteine, S-ethyl cysteine, and S-propyl cysteine, respectively.  In
addition, incorporation into free- and esterified- cholesterol was reduced in response to
increasing carbon chain length of cysteine derivatives.  Most remarkable reduction was
again noted by the treatment of S-propyl cysteine.  On the other hand, no differences were
noted in incorporation of [14C]acetate into cellular TAG, free- and esterified-cholesterol in
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the cells treated with cysteine derivatives as compared to those without these derivatives.
4. DISCUSSION
The present study showed that S-propyl cysteine derived from onion could reduce
apoB100 secretion by human liver cells, HepG2. High level of apoB100 is a risk factor for
atherosclerosis, so the reduction of apoB100 secretion by cysteine derivatives may be
beneficial for health.  Factors that regulate the synthesis and secretion of apoB100-
containing lipoproteins by liver cells are the availability of apoB100 and lipids and the
activity of microsomal TAG transfer protein (MTP) (Craig et al., 1988).  ApoB100, a 556
kDa hydrophobic protein, is synthesized in the endoplasmic reticulum and shows LDL-
receptor binding activity (Davis, 1999; Twisk et al., 2000).  After synthesis, it is stabilized
through binding with lipids, and then is secreted as apoB100-containing lipoproteins.  If
insufficient lipid is available, apoB100 is unstable and undergoes degradation via the
ubiquitin-proteasome pathway (Bonnardel and Davis, 1995; Fisher et al., 1997).
Therefore, the control of apoB100 expression in cells is considered to be post-
transcriptional (Gordon et al., 1996).
In HepG2 cells, S-propyl cysteine reduced the secretion of apoB100 compared
to untreated cells (Fig. 15).  ApoB100 is a major constituent of the lipoproteins produced
in the liver.  Therefore, the decreased secretion of apoB100 by HepG2 cells suggests that
hepatic secretion of apoB100-containing lipoprotein (VLDL) would be reduced.
Exposure of HepG2 cells to S-propyl cysteine reduced the secretion of [14C]TAG
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from [14C]acetate significantly (Fig.16), in spite of the [14C]acetate-incorporation into
cellular lipids did not alter.  These results suggest that S-propyl cysteine may inhibit the
process of lipoprotein assembly and secretion.  Liu and Yeh (2000) reported that S-propyl
cysteine at high concentration (50-4000 µM) inhibited fatty acid synthesis and thereby TAG
synthesis in cultured rat hepatocytes.  The discrepancy on fatty acid synthesis by S-propyl
cysteine between the present study and that by Liu and Yeh may be due to the difference
of concentrations used and cells used (rat hepatocytes versus HepG2 cells).  Cholesterol
metabolism also affects on lipoprotein synthesis (Yanagita et al., 1999).  In the present
study, the incubation with S-propyl cysteine markedly reduced the secretion of
[14C]cholesterol from [14C]acetate from the cells.  However, the incorporation rate of
[14C]acetate into cellular cholesterol was not changed, although it was slightly lower with
S-propyl cysteine treatment.
It is well recognized that MTP is an important factor involved in lipoprotein
synthesis by the liver (Jamil et al., 1997).  MTP is a heterodimer consisting of a 97 kDa
subunit with a lipid transfer activity and a 58 kDa subunit with a protein disulfide
isomerase activity, and is essential for the transfer of lipid to nascent lipoproteins (Gregg
and Wetterau, 1994).  Complete absence of MTP causes abetalipoproteinemia (Harrity
et al., 1998; Wetterau et al., 1992), while MTP inhibitors are reported to inhibit the
development of atherosclerosis in WHHL rabbits (Wetterau et al., 1998).  As described
in Chapter III, cycloalliin, a cyclic imino compound found in onion, caused a marked
reduction of the plasma TAG concentration.  Therefore, it is necessary to perform
investigations into the effect of sulfur amino acids on MTP activity and mRNA expression.
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It is noteworthy that the inhibitory effect of the cysteine derivatives on apoB100
secretion from the cells increased in the order of S-propyl cysteine, S-ethyl cysteine, and
S-methyl cysteine, indicating that the cysteine derivatives with a longer carbon chain had
a stronger inhibitory effect (Fig. 18).  An interaction of these compounds with the cell
membrane and their entry into the cells may be responsible for this difference in their
activity.  As incubation with S-propyl cysteine resulted to reduce the cellular TAG and
CE syntheses from [14C]oleate, one might suppose that the sulfur compound inhibits the
esterification of exogenous fatty acid to cellular lipids (Fig. 17).  But, there was no any
difference in cellular TAG synthesis from [14C]acetate.  Taken together, it is hypothesized
that S-propyl cysteine may reduce the transport of exogenous fatty acids into the cells.
In conclusion, S-propyl cysteine from onion reduced apoB100 secretion by
HepG2 cells derived from the human hepatoblastoma cells.  Accordingly, the beneficial
actions of foods including onion can be attributed to the presence of cysteine derivatives.
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　             Fig.13. Chemical structures of cysteine derivatives
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   Fig.14. Effect of various concentrations of S-propyl cysteine on the cytotoxicity
         and cell proliferation.
Semiconfluent HepG2 cells were preincubated in the DMEM containing 1 %     
BSA (basal medium) and 0.5 mM oleate for 24 h. Then, the cells were  
incubated in the basal medium containing various concentrations (0 to 1000
µM) of S-propyl cysteine for another 24 h. Data are expressed as a percentage
of the control and represent means ± SE of 4 samples.
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Fig.15.  Effect of S-propyl cysteine on the apoB100 secretion from HepG2 cells.
Semiconfluent HepG2 cells were preincubated in the DMEM containing 1 % BSA
and 0.5 mM oleate for 24 h. Then the cells were incubated in the medium
containing 10 µM of S-propyl cysteine for 3 and 24 h. After harvest, apoB100
content in the medium was measured by double antibody method, ELISA. Data
represent means ± SE of 4 samples. * p < 0.001.
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  Fig.16. Effect of S-propyl cysteine on the incorporation of [14C]acetate into TAG and   
        cholesterols and secretion into the medium.
 After preincubation with the DMEM containing 1 % BSA and 0.5 mM oleate   
 for 24 h, the cells were incubated in the same medium containing 10 µM of S-
 propyl cysteine and 18.5 kBq [14C]acetate for 24 h. See also Fig.15. The value
 of the incorporation of [14C]acetate into TAG in untreated cells ((685.6 ± 27.5)
 x 10-3 dpm/mg cell protein) and the secretion of the labeled TAG into the medium
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 ((16.1 ± 0.20) x 10-3 dpm/mg cell protein) were arbitrarily defined as 100,
respectively. The value of the incorporation of [14C]acetate into free cholesterol
in untreated cells ((66.1 ± 2.41) x 10-3 dpm/mg cell protein) and the secretion of
the labeled free cholesterol into the medium ((4.40 ± 0.24) x 10-3 dpm/mg cell
protein) were arbitrarily defined as 100, respectively. The value of the
incorporation of [14C]acetate into cholesterol ester in untreated cells ((16.1 ± 0.25)
x 10-3 dpm/mg cell protein) and the secretion of the labeled cholesterol ester into
the medium ((0.44 ± 0.04) x 10-3 dpm/mg cell protein) were arbitrarily defined
as 100, respectively. Data represent means ± SE of 4 samples. *Statistically
significant difference from control at p < 0.05.
Abbreviation: TAG; Triacylglycerol, FC; Free cholesterol, CE; Cholesterol ester.
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    Fig.17. Effect of S-propyl cysteine on the incorporation of [14C]oleate into TAG
          and cholesterol ester.
   After preincubation with the DMEM containing 1 % BSA and 0.5 mM oleate
   for 24 h, the cells were incubated in the medium containing 10 µM of S-propyl
   cysteine and 18.5 kBq [14C]oleate for 24 h. The value of the incorporation of
   [14C]oleate into TAG in untreated cells ((422 ± 27.8) x 10-3 dpm/mg cell
   protein) was arbitrarily defined as 100. The value of the incorporation of
   [14C]oleate into cholesterol in untreated cells ((5.71 ± 0.34) x 10-3 dpm/mg cell
   protein) was arbitrarily defined as 100. Data represent means ± SE of 4
   samples. * p < 0.05. Abbreviation: TAG; Triacylglycerol, CE; Cholesterol  
   ester.
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Fig.18. Effects of cysteine derivatives on the apoB100 secretion from HepG 2 cells.
After preincubation with the DMEM containing 1 % BSA and 0.5 mM oleate for
24 h, the cells were incubated in the medium containing 10 µM of cysteine
derivatives, S-methyl-, S-ethyl-, and S-propyl cysteines for 24 h. After harvest,
the secreted apolipoprotein B100 was measured by the method refered below
Fig.14. The value of the secreted apoB100 into the untreated medium ((2.08 ±
0.11) µg/mg cell protein) was arbitrarily defined as 100. Data represent means ±
SE of 4 samples. *Values not sharing the same letter are significantly different
at p < 0.05.
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 Fig.19. Effects of cysteine derivatives on the incorporation of [14C]acetate into TAG and
       cholesterols and secretion into the medium.
After preincubation, the cells were incubated in the same medium (See legend in
Fig.14) containing 10 µM of cysteine derivatives, S-methyl-, S-ethyl-, and S-
propyl cysteines and 18.5 kBq [14C]acetate for 24 h. The value of the
( arbitrary unit )
Control Methyl Ethyl  Propyl
　　　 cysteine (10µM)
0
25
50
75
100
0
25
50
75
100
Cell Medium
Control Methyl Ethyl  Propyl
　　　 cysteine (10µM)
( arbitrary unit )
a
a
b
c
(CE)
0
25
50
75
100
0
25
50
75
100
( arbitrary unit ) ( arbitrary unit )
Control Methyl Ethyl  Propyl
　　　 cysteine (10µM)
a
b
Cell Medium
Control Methyl Ethyl  Propyl
　　　 cysteine (10µM)
a
a
0
25
50
75
100
0
25
50
75
100
( arbitrary unit ) ( arbitrary unit )
Control Methyl Ethyl  Propyl
　　　 cysteine (10µM)
Control Methyl Ethyl  Propyl
　　　 cysteine (10µM)
a
b
b b
Cell Medium
(TAG)
(FC)
72
incorporation of [14C]acetate into TAG in untreated cells and the secretion of the
labeled TAG into the medium (as control) were arbitrarily defined as 100,
respectively. The value of the incorporation of [14C]acetate into free cholesterol
in untreated cells and the secretion of the labeled free cholesterol into the medium
(as control) were arbitrarily defined as 100, respectively. The value of the
incorporation of [14C]acetate into cholesterol ester in untreated cells and the
secretion of the labeled cholesterol ester into the medium (as control) were
arbitrarily defined as 100, respectively. Data represent means ± SE of 4 samples.
*Values not sharing the same letter are significantly different at p < 0.05.
Abbreviation: TAG; Triacylglycerol, FC; Free cholesterol, CE; Cholesterol ester.
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Part 2. Effects of cysteine- and methionine- sulfoxides on lipid and
apoB100-containing lipoprotein metabolism in HepG2 cells
1. INTRODUCTION
 
In previous parts, we reported that cycloalliin, a main sulfur-containing cyclic
compound in cooked onion, markedly reduced serum TAG concentration in rats fed the
atherogenic diet and, then the addition of cycloalliin to the culture medium reduced
apoB100 secretion in HepG2 cells.  In the previous part, S-propyl cysteine, S-ethyl
cysteine, and S-methyl cysteine found in onion and garlic are also a potent inhibitor for
apoB100 production in HepG2 cells.  These results prompted us to examine whether other
sulfur-containing compounds such as, propyl-cysteine sulfoxide, DL-methionine sulfoxide,
S-carboxymethyl cysteine, and S-carboxyethyl cysteine (Fig. 20), found in onion of Allium
species may also have biological activities such as alteration of apoB100-containing
lipoproteins metabolism.
2. MATERIALS AND METHODS
2.1 Experimental materials and reagents
HepG2 cells were obtained from Riken Cell Bank (Tsukuba, Japan).  DMEM
and trypsin were provided from Gibco (Grand Island, NY, USA).  The derivatives of
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cysteine and methionine are supplied from Nippon Shinyaku, Ltd. (Kyoto, Japan).  Other
reagents and radioactive materials were purchased as descrebed in Chapter II.
2.2 HepG2 cell culture
The HepG2 cells were precultured in the DMEM containing 1 % BSA and 0.5 mM
oleate for 24 h, and used for the experiments with the same methods as described in
Chapter II.
2.2.1 Experiment I
The cells were cultured in medium supplemented with or without S-propyl-
cysteine sulfoxide and DL-methionine sulfoxide, at the concentration of 10 µM for 24 h.
As a lipid precursor, 37 kBq of [14C]acetate was added into medium at the beginning of
experiment.  After incubation, the cells and the supernatants were harvested separately,
and frozen at -80 °C until analysis.
2.2.2 Experiment II
The cells were cultured in the medium supplemented with or without S-
carboxymethyl cysteine and S-carboxyethyl cysteine, at the different concentrations of 1-
100 µM for 24 h.  As a lipid precursor, 37 kBq of [14C]acetate was added into the
experimental medium at the beginning of experiment.  After incubation, the cells and the
supernatants were harvested separately, and frozen at -80 °C until analysis.
2.3 Preparation of experimental medium
Experimental mediums containing test amino compounds were sterilized after
passing through a 0.45 µm Millipore R filter.
75
2.4 Determination of cellular protein
Cells were distrupted with a sonicator (sonifier 250TM, Branson Ultradonid Co.,
Connecticut, USA), and the cellular protein concentration was determined as described in
Chapter II.
2.5 Cell viability
MTT assay was performed as described in Chapter II.
2.6 Accumulation of apoB100 in the medium by HepG2 cells
ApoB100 concentration was measured by a double antibody enzyme-linked
immunosorbent assay (ELISA) as described in Chapter II.
2.7 Lipid synthesis and secretion
The incorporation of [14C]acetate into cellular lipids and their secretion were
measured as described in Chapter II.
2.8 Statistical Analyses
Values are the means ± SE.  Data were analyzed by one-way ANOVA, all
differences being inspected by Duncan s new multiple-range test (Duncan, 1955).  A
difference was considered significant at p < 0.05.
3. RESULTS
3.1 Effect of S-propyl-cysteine sulfoxide and DL-methionine sulfoxide on apoB100
production (Experiment I)
Incubation with 10 µM of S-propyl-cysteine sulfoxide or DL-methionine
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sulfoxide with HepG2 cells for 24 h did not cause any untoward effects on cell viability
and intracellular protein concentration (Fig. 21).  Figure 22 shows the effect of apoB100
production by HepG2 cells cultured in the presence or absence of these sulfoxides.
Addition of S-propyl-cysteine sulfoxide and DL-methionine sulfoxide induced
approximately 35 % reduction in the accumulation of apoB100 in the mediums.
3.2 Effect of S-propyl-cysteine sulfoxide and DL-methionine sulfoxide on the
incorporation of [14C] acetate into cellular and medium TAG and cholesterol
Incorporation of [14C] acetate into TAG was comparable in the cells treated with
S-propyl-cysteine sulfoxide and DL-methionine sulfoxide or without test reagent (control)
for 24 h, while that into medium TAG was significantly lower in the cells treated with these
two sulfoxides as compared to the control, the extent of reductions being 37 % and 55 %
as compared to the control, respectively (Fig. 23).  The ability to reduce incorporation of
the label appeared to be higher in methionine sulfoxide than in propyl cysteine sulfoxide.
Incorporation of [14C]acetate into medium cholesterol (free and esterified) were
significantly reduced by these sulfoxides (Fig. 24).
3.3 Effect of S-carboxymethyl cysteine and S-carboxyethyl cysteine on the incorporation
of [14C]acetate into TAG and cholesterol and their secretion (Experiment II)
Addition of S-carboxymethyl cysteine and S-carboxyethyl cysteine at the
concentrations of 1 and 100 µM did not cause any deleterious effects on cell viability and
protein concentration of HepG2 cells (Fig. 25).  Incorporation of [14C] acetate into cellular
TAG following treatment with S-carboxymethyl cysteine and S-carboxyethyl cysteine as
compared to those treated without cysteine derivatives for 24 h was comparable (Fig. 26).
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On the other hand, incorporation of the label into medium TAG tended to be lower 25 %
by S-carboxymethyl cysteine treatment, and was significantly lowered 48 % in 1 µM S-
carboxyethyl cysteine (Fig. 26), suggesting an importance of chain-length of carbxyalkyl-
chain bound to cysteine on the synthesis of TAG.  When the cells were incubated with 100
µM S-carboxymethyl cysteine, the incorporation of the label was less than 50 % of the
control value.  With regard to cholesterol metabolism, effects of added cysteine
derivatives on the incorporation of [14C]acetate into cellular free- and cholesterol-
cholesterol were equivocal, whereas that into medium cholesterol counterpart were
apparent at the higher concentration of cysteine derivatives (Fig. 27).  Thus, incorporation
of label into free as well as cholesterol ester in the medium were significantly lowered by
the treatment of both S-carboxyalkyl cysteines.
4. DISCUSSION
The present study demonstrated that derivatives of cysteine and methionine, S-
propyl-cysteine sulfoxide, DL-methionine sulfoxide, S-carboxymethyl cysteine and S-
carboxyethyl cysteine found in onion and garlic, lower the secretion of apoB100 and lipids
in human liver cell model, HepG2.
It is known that liver is the pivotal organ concerned with lipid metabolism and
apoB100-containing lipoproteins assembly and secretion (Angelin and Gibbsons, 1993).
Overproduction of apoB100-containing lipoprotein in the liver results in hyperlipidemia
(Loscalzo and Sniderman, 1993).  Furthermore, higher concentrations of serum
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cholesterol, TAG, and apoB100 are major risk factors on CHD and atherosclerosis (Brewer,
1999).
HepG2 cells treated with S-propyl-cysteine sulfoxide and DL-methionine
sulfoxide reduced the accumulation of apoB100 in the cultured medium (Fig.22) compared
with the untreated cells.  ApoB100 is synthesized in the endoplasmic reticulum and
assembled as components of apoB100-containing lipoproteins (Craig et al., 1988; Hebbachi
et al., 1999).  Following synthesis, apoB100 is stabilized by binding to lipids, which is
then secreted as apoB100-containing lipoproteins.  If insufficient lipid is available,
apoB100 is unstable and undergoes degradation via the ubiquitin-proteasome pathway
(Fisher et al., 1997).  Therefore, it is believed that the control of apoB100 expression in
cells is mainly post-transcriptional (Goldberg and Ginsberg, 1997; Gordon et al., 1996).
It is known that VLDL assembly and secretion is dependent on the levels of TAG and
cholesterol ester, the rate of apoB100 catabolism after translation, and MTP activity
(Yanagita et al., 1999).  To evaluate the mechanism by which apoB100 levels are reduced
by the test compounds, we studied the cellular lipid synthesis and secretion by using
[14C]acetate as the lipid precursor.
S-Propyl-cysteine sulfoxide and DL-methionine sulfoxide significantly reduced
TAG secretion to the medium as shown in Fig. 23 and showed no effect on the
incorporation rate of [14C]acetate into cellular TAG.  The secretion of free cholesterol and
cholesterol ester were reduced significantly by the treatment with two sulfoxides as shown
in Fig. 24.  S-Carboxymethyl cysteine and S-carboxyethyl cysteine also reduced labeled
TAG, free cholesterol, and cholesterol ester secretion into the cultured medium (Figs.26
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and 27).  However, cells treated with S-carboxyalkyl cysteines also had no effect on the
incorporation of [14C]acetate into cellular TAG, free cholesterol and cholesterol ester.
These results raised the possibility that these compounds interfere with lipoprotein
assembly and secretion in the endoplasmic reticulum and Golgi apparatus.
MTP is necessary for the transfer of TAG, cholesterol and phospholipid, and
binding of apoB100, thus regulates the synthesis and secretion of nascent lipoproteins
(Jamil et al., 1998).  MTP is a soluble protein that is localized to the lumen of the
endoplasmic reticulum in cells from the liver and small intestine.  It exists as a 97 kDa
molecule with a lipid transfer activity or as a heterodimer of 58 kDa having an isomerase
activity (Erickson and Fielding, 1995). Depletion of MTP activity causes
abetalipoproteinemia (Wetterau et al., 1997; Wetterau et al., 1992).  In the previous study,
we showed that cycloalliin inhibited MTP activity in the liver, decreased serum TAG level
and apoB100 secretion (Wetterau et al., 1998).  We also showed that S-propyl cysteine
and S-ethyl cysteine found in onion reduced apoB100 secretion in HepG2 cells in the
previous part.
The exact mechanism by which S-propyl-cysteine sulfoxide and DL-methionine
sulfoxide reduced apoB100 and lipid secretion remained to be determined.  It is possible
that these compounds may inhibit MTP activity in the liver and thus interfere with
assembly and secretion of apoB100-containing lipoproteins in the liver.  It is also
necessary to investigate whether these sulfur-containing amino compounds alter MTP
activity and MTP mRNA expression.
In conclusion, the present study demonstrated that sulfur-amino acid derivatives
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in Allium species inhibited the secretion of apoB100 and lipids from the liver, which
suggests that they may be beneficial in atherosclerosis.
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　　　Fig.20. Chemical structures of the derivatives of cysteine and methionine.
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Fig.21. Effects of propyl-cysteine sulfoxide and DL-methionine sulfoxide on the
      cytotoxicity and cell proliferation.
 Semiconfluent HepG2 cells were preincubated in the DMEM containing   
 1 % BSA (basal medium) and 0.5 mM oleic acid for 24 h. After  
 preincubation, the cells were incubated in the basal medium containing 10
 µM of propyl-cysteine sulfoxide or DL-methionine sulfoxide for another
 24 h. The effect of sulfoxides on the cytotoxicity and cell proliferation
 were determined by MTT activity and cellular protein concentration. Data
 are expressed as a percentage of the control and represent means ± SE of
 4 samples. *Abbreviation: CON; control, PCS; propyl-cysteine sulfoxide,
 MS; DL-methionine sulfoxide.
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 Fig.22. Effects of propyl-cysteine sulfoxide and DL-methionine sulfoxide on the
       apoB100 secretion from HepG2 cells.
Semiconfluent HepG2 cells were preincubated in the DMEM containing
1 % BSA and 0.5 mM oleic acid for 24 h. And then the cells were incubated
in the medium containing 10 µM of propyl-cysteine sulfoxide or DL-
methionine sulfoxide for 24 h. After harvest, the secreted apoB100 was
measured by double antibody method, ELISA. Data represent means ± SE
of 4 samples. * Values with different letters are significantly different at p
< 0.001. Abbreviation: CON; control, PCS; propyl- cysteine sulfoxide, MS;
DL-methionine sulfoxide.
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 Fig.23. Effects of propyl-cysteine sulfoxide and DL-methionine sulfoxide on the  
       incorporation of [14C]acetate into TAG secretion into the medium.
After preincubation, the cells were incubated in the medium containing 10 µM
of propyl-cysteine sulfoxide or DL-methionine sulfoxide and 37 kBq [14C]acetate
for 24 h. The value of the incorporation of [14C]acetate into TAG in untreated cells
and the secretion of the labeled TAG into the medium (as control), 686 ± 27 and
16.1 ± 0.20 (x 10-3 dpm/mg cell protein) were arbitrarily defined as 100,
respectively. Values with different letters are significantly different at p < 0.05
*Abbreviation: CON; control, PCS; propyl-cysteine sulfoxide, MS; DL-
methionine sulfoxide.
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 Fig.24. Effects of propyl-cysteine sulfoxide and DL-methionine sulfoxide on the
       incorporation of [14C]acetate cholesterols and secretion into the medium.
The value of the incorporation of [14C]acetate into free cholesterol in untreated
cells and the secretion of the labeled free cholesterol into the medium (as
control) , 66.1 ± 2.41 and 4.40 ± 0.24 (x 10-3 dpm/mg cell protein) were arbitrarily
defined as 100, respectively. The value of the incorporation of [14C]acetate into
cholesterol ester in untreated cells and the secretion of the labeled cholesterol ester
into the medium (as control), 16.1 ± 0.25 and 0.44 ± 0.04 (x 10-3 dpm/mg cell
protein) were arbitrarily defined as 100, respectively. * Values with different
letters are significantly different at p < 0.05. Abbreviation: CON; control, PCS;
propyl-cysteine sulfoxide, MS; DL-methionine sulfoxide.
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Fig.25. Effects of S-carboxyalkyl cysteines on the cytotoxicity and cell proliferation.
Semiconfluent HepG2 cells were preincubated in the DMEM containing 1 % BSA
(basal medium) and 0.5 mM oleic acid for 24 h. After preincubation, the cells
were incubated in the basal medium containing 1, 100 µM of S-carboxyalkyl
cysteines for another 24 h. The effect of S-carboxyalkyl cysteines on the
cytotoxicity and cell proliferation were determined by MTT activity and cellular
protein concentration. Data are expressed as a percentage of the control and
represent means ± SE of 4 samples. *Abbreviation: CON; control, CMC;
carboxymethyl cysteine, CEC; carboxyethyl cysteine.
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 Fig.26. Effects of S-carboxyalkyl cysteines on the incorporation of [14C]acetate into
       TAG and secretions into the medium.
After preincubation, the cells were incubated in the medium containing 1, 100 µM
of S-carboxyalkyl cysteines and 37 kBq [14C]acetate for 24 h. The value of the
incorporation of [14C]acetate into TAG in untreated cells (as control), 628 ± 63 (x
10-3 dpm/mg cell protein) was arbitrarily defined as 100, respectively. The value
of the secretion of the labeled TAG into the medium (as control) , 13.6 ± 1.8 (x
10-3 dpm/mg cell protein) was arbitrarily defined as 100, respectively. *Values
with different letters are significantly different at p < 0.05. Abbreviation: CON;
control, CMC; carboxymethyl cysteine, CEC; carboxyethyl cysteine.
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 Fig.27. Effects of S-carboxyalkyl cysteines on the incorporation of [14C]acetate into
       cholesterols and secretion into the medium.
The value of the incorporation of [14C]acetate into free cholesterol in untreated
cells and the secretion of the labeled free cholesterol into the medium (as
control) , 75 ± 7 and 8.5 ± 1.2 (x 10-3 dpm/ mg cell protein) were arbitrarily
defined as 100, respectively. The value of the incorporation of [14C]acetate into
cholesterol ester in untreated cells and the secretion of the labeled cholesterol ester
into the medium (as control), 19.2 ± 1.9 and 0.33 ±  0.05 (x 10-3 dpm/ mg cell
protein) were arbitrarily defined as 100, respectively. * Values with different
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letters are significantly different at p < 0.05. Abbreviation: CON; control, CMC;
carboxymethyl cysteine, CEC; carboxyethyl cysteine.
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CHAPTER V
SUMMARY & CONCLUSIONS
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SUMMARY & CONCLUSIONS
Along with changes in dietary habits and lifestyle, various lifestyle-related
diseases have been increasing, such as hyperlipidemia, obesity, diabetes, and
hypertension, which all involve abnormalities of lipid metabolism.  Vegetables and fruits
are important nutrients for humanbeings and some of them contain various ingredients
that exhibit physiological effects.  Liliaceous plants (Allium species) such as onions and
garlic have been long used as traditional medicines and are thought to have various
effects, including prevention of heart diseases.  It is reported that they contain abundant
amounts of sulfur-containing compounds.  In the preliminary study, we found that
dietary onion reduced serum TAG level and adipose tissue weight.
To extend their therapeutic application and also to find the component
responsible for the nutraceutical actions, we investigated the effects of several sulfur-
containing compounds on the lipid and lipoprotein metabolism in experimental animals
and human hepatoma cell line, HepG2.  
In Chapter II, we investigated that dietary onion extract on tissue weight and
lipid metabolism in rats.  We found that dietary onion extract exerts for a
hypotriglyceridemic action which was associated with a decrease in adipose tissue
weights. in the rat fed atherogenic diet
In Chapter III, we evaluated that dietary cycloalliin, a cyclic sulfur-containing
imino acid, on lipid and the related enzyme activities in rats and in HepG2 cells.
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Cycloalliin reduced serum TAG level and the activity of microsomal TAG
transfer protein, a factor for regulating the synthesis and secretion of apoB100-containing
lipoproteins, VLDL.  Furthermore, we found that cycloalliin reduced apoB100 and TAG
secretion in HepG2 cells.  Taken together, cycloalliin appears to inhibit VLDL assembly
in the liver.
In Chapter IV, we evaluated that the effect of several derivatives of cysteine and
methionine found in onion on lipid and apoB100-containing lipoprotein metabolism in
HepG2 cells.  The addition of S-methyl-, S-ethyl-, and S-propyl-cysteines, propyl-
cysteine sulfoxide and DL-methionine sulfoxide resulted to reduce markedly TAG and
apoB100 secretion to the medium.  S-Carboxymethyl- and S-carboxyethyl cysteines also
reduced TAG, free cholesterol, and cholesterol ester secretion to the cultured medium.  In
addition, the length of carbon chain bound to cysteine derivative is important for lipid
metabolism.
In conclusion, the present study demonstrated for the first time that cycloalliin
is a potent inhibitor of apoB100-containing lipoprotein assembly and MTP activity in the
liver.  In addition, other sulfur-containing amino derivatives such as S-methyl-, S-ethyl-,
and S-propyl-cysteines, S-propyl-cysteine sulfoxide, DL-methionine sulfoxide, S-
carboxymethyl cysteine, and S-carboxyethyl cysteine exhibit inhibitory effects on the
production of apoB100 as well as on the secretion of lipids from the liver. These results
suggest that the consumption of these vegetables is favorable for preventing and/or
ameliorating certain disease caused by lipid metabolism disorders.
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